Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Cash from Financing Activities: 2023-2024

Historic Cash from Financing Activities for Camp4 Therapeutics (CAMP) over the last 2 years, with Dec 2024 value amounting to $71.7 million.

  • Camp4 Therapeutics' Cash from Financing Activities rose 12375.65% to $47.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.4 million, marking a year-over-year increase of 8327.41%. This contributed to the annual value of $71.7 million for FY2024, which is 23707.97% up from last year.
  • According to the latest figures from FY2024, Camp4 Therapeutics' Cash from Financing Activities is $71.7 million, which was up 23,707.97% from $301,000 recorded in FY2023.
  • Camp4 Therapeutics' Cash from Financing Activities' 5-year high stood at $71.7 million during FY2024, with a 5-year trough of $301,000 in FY2023.
  • Moreover, its 2-year median value for Cash from Financing Activities was $36.0 million (2023), whereas its average is $36.0 million.
  • Data for Camp4 Therapeutics' Cash from Financing Activities shows a peak YoY surged of 23,707.97% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Camp4 Therapeutics' Cash from Financing Activities stood at $301,000 in 2023, then surged by 23,707.97% to $71.7 million in 2024.